These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 39009409)

  • 1. Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis.
    Volkmann ER; Denton CP; Kolb M; Wijsenbeek-Lourens MS; Emson C; Hudson K; Amatucci AJ; Distler O; Allanore Y; Khanna D
    Eur Respir Rev; 2024 Apr; 33(172):. PubMed ID: 39009409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing Dual Inhibitors of Autotaxin-LPAR GPCR Axis.
    Banerjee S; Lee S; Norman DD; Tigyi GJ
    Molecules; 2022 Aug; 27(17):. PubMed ID: 36080255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of lysophosphatidic acid pathway modulators as therapies for fibrosis.
    Budd DC; Qian Y
    Future Med Chem; 2013 Oct; 5(16):1935-52. PubMed ID: 24175745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic targeting of the ATX/LPA axis attenuates bleomycin-induced pulmonary fibrosis.
    Ninou I; Kaffe E; Müller S; Budd DC; Stevenson CS; Ullmer C; Aidinis V
    Pulm Pharmacol Ther; 2018 Oct; 52():32-40. PubMed ID: 30201409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.
    Castelino FV; Bain G; Pace VA; Black KE; George L; Probst CK; Goulet L; Lafyatis R; Tager AM
    Arthritis Rheumatol; 2016 Dec; 68(12):2964-2974. PubMed ID: 27390295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis.
    Oikonomou N; Mouratis MA; Tzouvelekis A; Kaffe E; Valavanis C; Vilaras G; Karameris A; Prestwich GD; Bouros D; Aidinis V
    Am J Respir Cell Mol Biol; 2012 Nov; 47(5):566-74. PubMed ID: 22744859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging Pulmonary Fibrosis and Treatment Efficacy In Vivo with Autotaxin-Specific PET Ligand [
    Deng X; Liu J; Zhou J; Shi Y; Song S; Chen J; Li Y; Yu B; Liang SH; Zhu X
    Mol Pharm; 2024 Oct; 21(10):5171-5181. PubMed ID: 39186477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autotaxin emerges as a therapeutic target for idiopathic pulmonary fibrosis: limiting fibrosis by limiting lysophosphatidic acid synthesis.
    Tager AM
    Am J Respir Cell Mol Biol; 2012 Nov; 47(5):563-5. PubMed ID: 23125419
    [No Abstract]   [Full Text] [Related]  

  • 9. Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis.
    Black KE; Berdyshev E; Bain G; Castelino FV; Shea BS; Probst CK; Fontaine BA; Bronova I; Goulet L; Lagares D; Ahluwalia N; Knipe RS; Natarajan V; Tager AM
    FASEB J; 2016 Jun; 30(6):2435-50. PubMed ID: 27006447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autotaxin-Lysophosphatidate Axis: Promoter of Cancer Development and Possible Therapeutic Implications.
    Laface C; Ricci AD; Vallarelli S; Ostuni C; Rizzo A; Ambrogio F; Centonze M; Schirizzi A; De Leonardis G; D'Alessandro R; Lotesoriere C; Giannelli G
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autotaxin inhibitors: a patent review (2012-2016).
    Nikolaou A; Kokotou MG; Limnios D; Psarra A; Kokotos G
    Expert Opin Ther Pat; 2017 Jul; 27(7):815-829. PubMed ID: 28447479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine lysophosphatidic acid signaling activates β-catenin and promotes lung allograft fibrosis.
    Cao P; Aoki Y; Badri L; Walker NM; Manning CM; Lagstein A; Fearon ER; Lama VN
    J Clin Invest; 2017 Apr; 127(4):1517-1530. PubMed ID: 28240604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autotaxin-LPA axis regulates hMSC migration by adherent junction disruption and cytoskeletal rearrangement via LPAR1/3-dependent PKC/GSK3β/β-catenin and PKC/Rho GTPase pathways.
    Ryu JM; Han HJ
    Stem Cells; 2015 Mar; 33(3):819-32. PubMed ID: 25376707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis.
    Gotoh M; Fujiwara Y; Yue J; Liu J; Lee S; Fells J; Uchiyama A; Murakami-Murofushi K; Kennel S; Wall J; Patil R; Gupte R; Balazs L; Miller DD; Tigyi GJ
    Biochem Soc Trans; 2012 Feb; 40(1):31-6. PubMed ID: 22260662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LPA and Autotaxin: Potential Drug Targets in Asthma?
    Georas SN
    Cell Biochem Biophys; 2021 Sep; 79(3):445-448. PubMed ID: 34331220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis.
    Magkrioti C; Oikonomou N; Kaffe E; Mouratis MA; Xylourgidis N; Barbayianni I; Megadoukas P; Harokopos V; Valavanis C; Chun J; Kosma A; Stathopoulos GT; Bouros E; Bouros D; Syrigos K; Aidinis V
    Cancer Res; 2018 Jul; 78(13):3634-3644. PubMed ID: 29724718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma.
    Onallah H; Catane LJ; Tropé CG; Hetland Falkenthal TE; Reich R; Davidson B
    Virchows Arch; 2018 Oct; 473(4):463-470. PubMed ID: 30032361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.
    Tabuchi S
    Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autotaxin induces lung epithelial cell migration through lysoPLD activity-dependent and -independent pathways.
    Zhao J; He D; Berdyshev E; Zhong M; Salgia R; Morris AJ; Smyth SS; Natarajan V; Zhao Y
    Biochem J; 2011 Oct; 439(1):45-55. PubMed ID: 21696367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A defective lysophosphatidic acid-autophagy axis increases miscarriage risk by restricting decidual macrophage residence.
    Yang HL; Lai ZZ; Shi JW; Zhou WJ; Mei J; Ye JF; Zhang T; Wang J; Zhao JY; Li DJ; Li MQ
    Autophagy; 2022 Oct; 18(10):2459-2480. PubMed ID: 35220880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.